Loading interface...

Eme 0.075 mg Injection

Manufactured byINTAS PHARMACEUTICALS LTD
ContainsPalonosetron
Description
Eme 0.075 mg Injection is an antiemetic medicine used to prevent nausea and vomiting associated with cancer chemotherapy. It is also used for the treatment and prevention of nausea and vomiting associated with the surgeries. This medicine is usually given 30 to 60 minutes prior to the start of chemotherapy.

Side effects

Major & minor side effects for Eme 0.075 mg Injection

  • Headache
  • Dry mouth
  • Chills
  • Blurred vision
  • Difficulty in breathing
  • Chest discomfort
  • Dizziness
  • Pain at the injection site

Uses of Eme 0.075 mg Injection

What is it prescribed for?

  • Chemotherapy induced nausea and vomiting
  • Post operative nausea and vomiting
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine is observed with 30 minutes.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for the maximum duration of 7 days.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or may prescribe an alternative medicine based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to palonosetron or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or may prescribe an alternative medicine based on your clinical condition.
General warnings

Use in children

This medicine is not recommended for use in patients below 18 years of age for prevention of postoperative nausea and vomiting since the safety and efficacy of use for this indication are not clinically established.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Tramadol

Azithromycin

Clozapine

Tacrolimus

Dextromethorphan

Ibutilide

Disease interactions

Renal impairment

This medicine should be used with caution in patients with renal impairment due to the increased risk of severe adverse effects. Close monitoring of renal function, appropriate dose adjustments, or replacement with suitable alternative may be required in some cases based on the clinical condition.

Hepatic impairment

This medicine should be used with caution in patients with hepatic impairment. Close monitoring of the hepatic function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine blocks the action of certain natural substances that can trigger nausea and vomiting.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antiemetics, 5HT3 receptor antagonists

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2018 [cited 10 January 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021372s018s019lbl.pdf

Palonosetron - DrugBank [Internet]. Drugbank.ca. 2018 [cited 10 January 2018]. Available from:

https://www.drugbank.ca/drugs/DB00377

Palonosetron Injection: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 10 January 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a610002.html

[Internet]. 2018 [cited 10 January 2018]. Available from:

https://www.medicines.org.uk/emc/product/513

DailyMed -palonosetron hydrochloride injection [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 10 January 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4216772-6c37-4ff0-a575-f758390656e3
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.